Covered recipient · General Payments record
ANDREW MACKNAIR
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2023
$3,299.63
- Reported across 178 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $313.84 | 17 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $78.44 | 4 |
| Lilly USA, LLC | $64.86 | 4 |
| Halozyme Inc | $42.34 | 2 |
| SANOFI PASTEUR INC. | $41.91 | 2 |
| Novo Nordisk AS | $20.94 | 1 |
| Amgen Inc. | $18.88 | 1 |
| TOLMAR, INC. | $15.90 | 1 |
| Merck Sharp & Dohme Corporation | $15.48 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.51 | 06/15/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1006063589 | CMS |
| ABBVIE INC. | $19.72 | 07/12/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1006063591 | CMS |
| ABBVIE INC. | $14.45 | 07/13/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1006063593 | CMS |
| ABBVIE INC. | $20.76 | 10/05/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1006063595 | CMS |
| Amgen Inc. | $18.88 | 07/19/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1020234417 | CMS |
| Lilly USA, LLC | $14.45 | 06/05/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1032705097 | CMS |
| Lilly USA, LLC | $14.97 | 06/16/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1032559603 | CMS |
| Lilly USA, LLC | $14.85 | 08/01/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1032678093 | CMS |
| Lilly USA, LLC | $20.59 | 08/03/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1032505563 | CMS |
| Merck Sharp & Dohme LLC | $15.48 | 06/05/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1048893981 | CMS |
| Novartis Pharmaceuticals Corporation | $15.09 | 08/17/2023 | Food and Beverage | Undisputed | 06/30/2026 | 992941509 | CMS |
| Novo Nordisk Inc | $20.94 | 07/19/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1001934505 | CMS |
| SANOFI PASTEUR INC. | $20.66 | 06/14/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1044051423 | CMS |
| SANOFI PASTEUR INC. | $21.25 | 07/27/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1044051443 | CMS |
| Supernus Pharmaceuticals, Inc. | $21.12 | 06/09/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1054564431 | CMS |
| Supernus Pharmaceuticals, Inc. | $21.22 | 07/07/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1054564441 | CMS |
| Tolmar, Inc. | $15.90 | 07/24/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1056943821 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.